AtriCure (ATRC) Short Interest Ratio & Short Volume → Bill Clinton Backing Biden Replacement??? (From The Freeport Society) (Ad) Free ATRC Stock Alerts $23.14 +0.51 (+2.25%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media AtriCure Short Interest DataCurrent Short Volume2,980,000 sharesPrevious Short Volume3,200,000 sharesChange Vs. Previous Month-6.88%Dollar Volume Sold Short$71.88 millionShort Interest Ratio / Days to Cover3.8Last Record DateApril 30, 2024Outstanding Shares47,590,000 sharesPercentage of Shares Shorted6.26%Today's Trading Volume533,655 sharesAverage Trading Volume814,542 sharesToday's Volume Vs. Average66% Short Selling AtriCure ? Sign up to receive the latest short interest report for AtriCure and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatATRC Short Interest Over TimeATRC Days to Cover Over TimeATRC Percentage of Float Shorted Over Time Ad Porter & CompanyHow Biden has already won 2024Obama’s Forever Term [Exposed] or Obama Biden has already won 2024 Exposed: the shocking election plot that will forever enshrine Obama’s destructive, Marxist vision for America… A plot that could hand him and his allies near-total control over the government, your way of life, and your future.Click here to watch this now before it’s too late. AtriCure Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20242,980,000 shares $71.88 million -6.9%N/A3.8 $24.12 4/15/20243,200,000 shares $73.28 million -1.5%N/A4.5 $22.90 3/31/20243,250,000 shares $98.87 million +9.4%N/A4.9 $30.42 3/15/20242,970,000 shares $95.46 million +25.3%N/A4.8 $32.14 2/29/20242,370,000 shares $82.88 million +1.3%N/A4.1 $34.97 2/15/20242,340,000 shares $80.05 million +5.4%N/A3.9 $34.21 Get the Latest News and Ratings for ATRC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for AtriCure and its competitors with MarketBeat's FREE daily newsletter. 1/31/20242,220,000 shares $75.61 million +15.0%N/A4.1 $34.06 1/15/20241,930,000 shares $67.53 million +12.2%N/A3.6 $34.99 12/31/20231,720,000 shares $61.39 million -11.3%N/A3.3 $35.69 12/15/20231,940,000 shares $69.18 million -1.0%N/A3.9 $35.66 11/30/20231,960,000 shares $69.54 million +21.0%N/A4.2 $35.48 11/15/20231,620,000 shares $68.90 million +18.3%N/A4.5 $42.53 10/31/20231,370,000 shares $47.46 million +16.1%N/A4 $34.64 10/15/20231,180,000 shares $43.18 million -4.8%N/A3.6 $36.59 9/30/20231,240,000 shares $54.31 million -7.5%N/A3.8 $43.80 9/15/20231,340,000 shares $59.83 million +8.9%N/A4.3 $44.65 8/31/20231,230,000 shares $55.53 million +35.1%N/A4 $45.15 8/15/2023910,700 shares $47.27 million +14.3%N/A3.1 $51.90 7/31/2023796,700 shares $44.10 million -22.7%N/A2.8 $55.35 7/15/20231,030,000 shares $54.32 million -9.7%N/A3.6 $52.74 6/30/20231,140,000 shares $56.27 million -22.5%N/A4.3 $49.36 6/15/20231,470,000 shares $72.21 million -16.0%N/A5.3 $49.12 5/31/20231,750,000 shares $78.70 million +2.9%N/A5.8 $44.97 5/15/20231,700,000 shares $81.52 million -3.4%N/A5.1 $47.95 4/30/20231,760,000 shares $77.42 million +2.9%N/A5 $43.99 4/15/20231,710,000 shares $72.59 million No Change3.8%5 $42.45 3/31/20231,710,000 shares $70.88 million +1.8%3.8%5 $41.45 3/15/20231,680,000 shares $65.76 million -6.7%3.7%5 $39.14 2/28/20231,800,000 shares $69.30 million +13.2%4.0%5.9 $38.50 2/15/20231,590,000 shares $67.42 million +34.8%3.5%5.5 $42.40 1/31/20231,180,000 shares $51.07 million -8.5%2.6%4.6 $43.28 1/15/20231,290,000 shares $55.64 million -10.4%2.8%4.8 $43.13 12/30/20221,440,000 shares $63.91 million +18.0%3.2%5 $44.38 12/15/20221,220,000 shares $51.81 million -5.4%2.7%4.1 $42.47 11/30/20221,290,000 shares $58.77 million -2.3%2.9%4.4 $45.56 11/15/20221,320,000 shares $62.63 million +9.1%2.9%4.3 $47.45 10/31/20221,210,000 shares $50.97 million -11.0%2.7%4.1 $42.12 10/15/20221,360,000 shares $45.53 million -15.5%3.0%5.1 $33.48 9/30/20221,610,000 shares $62.95 million -4.7%3.6%6.3 $39.10 9/15/20221,690,000 shares $77.57 million -12.0%3.8%6.6 $45.90Bill Clinton Backing Biden Replacement??? (Ad)Bill Clinton is back. And he just met in Mexico with the one person I believe could REPLACE Joe Biden by August…Click here now for my urgent election forecast. ATRC Short Interest - Frequently Asked Questions What is AtriCure's current short interest? Short interest is the volume of AtriCure shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 2,980,000 shares of ATRC short. Learn More on AtriCure's current short interest. What is a good short interest ratio for AtriCure? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ATRC shares currently have a short interest ratio of 4.0. Learn More on AtriCure's short interest ratio. Which institutional investors are shorting AtriCure? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of AtriCure: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is AtriCure's short interest increasing or decreasing? AtriCure saw a drop in short interest in April. As of April 30th, there was short interest totaling 2,980,000 shares, a drop of 6.9% from the previous total of 3,200,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does AtriCure's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to AtriCure: Orthofix Medical Inc. (10.79%), Alphatec Holdings, Inc. (8.70%), Surmodics, Inc. (3.63%), Integra LifeSciences Holdings Co. (3.67%), Artivion, Inc. (7.11%), MiMedx Group, Inc. (3.83%), Embecta Corp. (4.81%), Atrion Co. (8.86%), Silk Road Medical, Inc (10.34%), OrthoPediatrics Corp. (6.82%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short AtriCure stock? Short selling ATRC is an investing strategy that aims to generate trading profit from AtriCure as its price is falling. ATRC shares are trading up $0.51 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against AtriCure? A short squeeze for AtriCure occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ATRC, which in turn drives the price of the stock up even further. How often is AtriCure's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ATRC, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Orthofix Medical Short Interest Data Alphatec Short Interest Data Surmodics Short Interest Data Integra LifeSciences Short Interest Data Artivion Short Interest Data MiMedx Group Short Interest Data Embecta Short Interest Data Atrion Short Interest Data Silk Road Medical Short Interest Data OrthoPediatrics Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ATRC) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressMost important medical advance in 100 yearsThe Oxford ClubUrgent Nvidia WarningAltimetryShocking $16T Elon Musk Crypto LeakCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingNext President (Not Trump. Not Biden.)The Freeport Society41 banks launch ‘crypto dollar’Stansberry ResearchWhat’s Really Next for America…Porter & Company